1. U. S. Food and Drug Administration: Tobacco Product Standard for Nicotine Level of Combusted Cigarettes. In., vol. 1130. 21 CFR; 2018: 11818-11843.
2. Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS et al: Randomized Trial of Reduced-Nicotine Standards for Cigarettes. The New England journal of medicine 2015, 373(14):1340-1349.
3. Benowitz NL, Nardone N, Hatsukami DK, Donny EC: Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev 2015, 24(2):331-335.
4. Nardone N, Donny EC, Hatsukami DK, Koopmeiners JS, Murphy SE, Strasser AA, Tidey JW, Vandrey R, Benowitz NL: Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes. Addiction (Abingdon, England) 2016, 111(12):2208-2216.
5. Goldstein JA, Goldstein LK: Randomized Trial of Reduced-Nicotine Standards for Cigarettes. The New England journal of medicine 2016, 374(4):395-396.
6. Foulds J, Hobkirk A, Wasserman E, Richie J, Veldheer S, Krebs NM, Reinhart L, Muscat J: Estimation of compliance with exclusive smoking of very low nicotine content cigarettes using plasma cotinine. Preventive medicine 2018, 117:24-29.
7. Dermody SS, Donny EC, Hertsgaard LA, Hatsukami DK: Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation. Tobacco control 2015, 24(6):536-539.
8. Hatsukami DK, Donny EC, Koopmeiners JS, Benowitz NL: Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015, 24(2):472-476.
9. Hammond D, O'Connor RJ: Reduced nicotine cigarettes: smoking behavior and biomarkers of exposure among smokers not intending to quit. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014, 23(10):2032-2040.
10. Mercincavage M, Souprountchouk V, Tang KZ, Dumont RL, Wileyto EP, Carmella SG, Hecht SS, Strasser AA: A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016, 25(7):1125-1133.
11. Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ et al: Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. Jama 2018, 320(9):880-891.
12. Denlinger RL, Smith TT, Murphy SE, Koopmeiners JS, Benowitz NL, Hatsukami DK, Pacek LR, Colino C, Cwalina SN, Donny EC: Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes. Tobacco regulatory science 2016, 2(2):186-203.
13. Nicotine Research Cigarettes Drug Supply Program [
https://www.drugabuse.gov/nicotine-research-cigarette-drug-supply-program]
14. Cassidy RN, Colby SM, Tidey JW, Jackson KM, Cioe PA, Krishnan-Sarin S, Hatsukami D: Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations. Drug and alcohol dependence 2018, 188:153-160.
15. Faulkner P, Ghahremani DG, Tyndale RF, Cox CM, Kazanjian AS, Paterson N, Lotfipour S, Hellemann GS, Petersen N, Vigil C et al: Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2017, 42(8):1610-1618.
16. Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Hughes JR, Stitzer ML, Durand H, Bunn JY, Priest JS et al: Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction. JAMA psychiatry 2017, 74(10):1056-1064.
17. Perkins KA, Kunkle N, Karelitz JL: Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers. Psychopharmacology 2017, 234(8):1255-1265.
18. Perkins KA, Kunkle N, Karelitz JL, Michael VC, Donny EC: Threshold dose for discrimination of nicotine via cigarette smoking. Psychopharmacology 2016, 233(12):2309-2317.
19. Shiffman S, Kurland BF, Scholl SM, Mao JM: Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial. JAMA psychiatry 2018.
20. Jarvis MJ, Russell MA, Benowitz NL, Feyerabend C: Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. American journal of public health 1988, 78(6):696-698.
21. Benowitz NL, Jacob P, 3rd: Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clinical pharmacology and therapeutics 1994, 56(5):483-493.
22. Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P, 3rd: Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007, 16(11):2479-2485.
23. Mercincavage M, Smyth JM, Strasser AA, Branstetter SA: Reduced Nicotine Content Expectancies Affect Initial Responses to Smoking. Tobacco regulatory science 2016, 2(4):309-316.
24. Benowitz NL, Nardone N, Dains KM, Hall SM, Stewart S, Dempsey D, Jacob P, 3rd: Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. Addiction (Abingdon, England) 2015, 110(10):1667-1675.
25. Ding YS, Richter P, Hearn B, Zhang L, Bravo R, Yan X, Perez JJ, Chan M, Hughes J, Chen P et al: Chemical Characterization of Mainstream Smoke from SPECTRUM Variable Nicotine Research Cigarettes. Tobacco regulatory science 2017, 3(1):81-94.
26. Richter P, Steven PR, Bravo R, Lisko JG, Damian M, Gonzalez-Jimenez N, Gray N, Keong LM, Kimbrell JB, Kuklenyik P et al: Characterization of SPECTRUM Variable Nicotine Research Cigarettes. Tobacco regulatory science 2016, 2(2):94-105.
27. Mendes P, Liang Q, Frost-Pineda K, Munjal S, Walk RA, Roethig HJ: The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US. Regul Toxicol Pharmacol 2009, 55(1):17-27.
28. Theophilus EH, Coggins CR, Chen P, Schmidt E, Borgerding MF: Magnitudes of biomarker reductions in response to controlled reductions in cigarettes smoked per day: a one-week clinical confinement study. Regul Toxicol Pharmacol 2015, 71(2):225-234.
29. Jarvis MJ, Foulds J, Feyerabend C: Exposure to passive smoking among bar staff. British journal of addiction 1992, 87(1):111-113.
30. Roethig HJ, Munjal S, Feng S, Liang Q, Sarkar M, Walk RA, Mendes PE: Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2009, 11(10):1216-1225.
31. Hatsukami DK, Luo X, Dick L, Kangkum M, Allen SS, Murphy SE, Hecht SS, Shields PG, al'Absi M: Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial. Addiction (Abingdon, England) 2016, 112(1):156-167.